share_log

Aurinia Pharmaceuticals | 4/A: Statement of changes in beneficial ownership of securities (and amendment thereto)-Director Jayne David R.W.

Aurinia Pharmaceuticals | 4/A:持股变动声明(修正)-董事 Jayne David R.W.

2022/07/11 06:16
声明:本内容仅用作提供资讯及教育之目的,不构成对任何特定投资或投资策略的推荐或认可。 更多信息